Clinical Trials
2 trialsNCT04135092 2020-09-04
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
No longer available
NCT04194190 2020-09-04
A Single Patient Will be Treated With Individual Patient TCR-Transduced PBL
National Institutes of Health Clinical Center (CC)
No longer available